ACCELERATING NOVEL SCIENCE
TO CREATE NEW MEDICINES
At the Global BioAccess Fund we partner with forward-thinking companies to create the medicines of tomorrow. We invest in transformative technologies that address unmet needs in oncology, cardiovascular, CNS, and rare diseases.
The Global BioAccess Fund invests in companies developing novel therapeutics and devices to address serious unmet medical needs in oncology, rare disease, CNS and cardiology. We fund early-stage companies who need capital to support IND submission and clinical trials.